06/16/2021 | Press release | Distributed by Public on 06/16/2021 14:06
Exhibit 16.1
June 16, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 4.01 of Vitality Biopharma Inc.'s Form 8-K dated June 16, 2021, and agree with the statements made in Item 4.01(a). We have no basis to agree or disagree with other statements of the registrant contained therein.
Yours truly,
/s/ Weinberg & Company, P.A.
Los Angeles, California